longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

07:45 ETAdvaita Bio Launches iSCanGuide™: Unified Single-Cell and Spatial Transcriptomics Analysis, Powered by GPU-Accelerated Infrastructure

prnewswire
May 7, 2026 at 11:45 AM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Advaita Bio has launched iSCanGuide, a cloud-based platform designed to streamline single-cell and spatial transcriptomics analysis. This GPU-accelerated platform integrates fragmented workflows, reducing analysis time from weeks to minutes. Key features include a user-friendly interface, standardized workflows, and support for various data formats. iSCanGuide connects to Advaita's iPathwayGuide for comprehensive pathway analysis, enhancing researchers' ability to derive insights from complex datasets. The platform aims to simplify the analysis process, making it accessible for both novice and expert users.

GPU-Accelerated Platform Unifies Fragmented Workflows, Turning Weeks of Analysis into Minutes

, /PRNewswire/ -- Advaita Bio today announced the launch of iSCanGuide, a cloud-based platform engineered to transform large-scale single-cell and spatial transcriptomics datasets into biologically meaningful results. Built on 20 years of validated science, the platform is integrated with Advaita's flagship platform, iPathwayGuide™, replacing fragmented workflows with a unified, GPU-powered discovery environment.

Single-cell and spatial transcriptomics generate complex datasets — but most researchers are still stitching together fragmented tools to analyze them, writing custom scripts, exporting between platforms, and losing weeks to manual workflows. iSCanGuide eliminates that bottleneck with a unified, GPU-accelerated environment that turns what used to take weeks into minutes, built on the same validated science that underpins Advaita's pathway analysis platform, trusted by over 13,000 researchers worldwide.

"Researchers are drowning in data and starving for insight," said Mike Mattacola, CEO of Advaita Bio. "iSCanGuide collapses what used to be a weeks-long manual process into minutes — from count matrices to annotated cell types, spatial context, and mechanistic pathway analysis in a single platform."

Key Features & Compatibility:

  • Real-Time Interaction: GUI-driven, zero-code interface with multiple navigation modes — accessible enough for first-time users, powerful for expert analysis.
  • Standardized Best-Practice Workflows: Ensure reproducibility and consistency across single-cell and spatial transcriptomics experiments with standardized, validated analysis pipelines.
  • Single-Cell Transcriptomics Analysis: Natively supports .h5ad, .h5, 10x CellRanger, and ParseBio outputs, enabling interactive and iterative analysis from initial QC and filtering through clustering, annotation, and trajectory analysis, with flexible workflows that adapt to your data at every stage.
  • Spatial Transcriptomics Analysis: Map gene expression in its native tissue context with full support for 10x Genomics Visium (Standard/HD) and Xenium. Visualize spatial cell distributions and identify spatially variable genes — all within the same environment used for single-cell RNA-seq, with no data export required.
  • Integrated Frameworks: Feeds directly into iPathwayGuide™ proprietary Impact Analysis methodology for mechanistic pathway analysis at single-cell resolution — connecting cell type annotation to pathway-level biological interpretation in a single workflow.
  • Cell-to-Cell Communication Analysis: Characterise intercellular signalling networks by identifying ligand-receptor interactions and communication patterns across cell types — revealing how cells coordinate behaviour within their native tissue environment.

"Single-cell and spatial analysis has been defined by fragmentation — too many tools, too many parameters, and no continuity between clustering and biological interpretation. The steep learning curve means critical know-how walks out the door every time an analyst leaves, and sharing results is harder than it should be," said Dr. Sorin Draghici, Founder and Chief Scientific Officer. "iSCanGuide replaces all of that with a single platform that takes researchers from count matrices to mechanistic pathway understanding — with sensible defaults, one-click sharing, and every setting captured. It connects directly to iPathwayGuide's proprietary Impact Analysis methodology, so the entire workflow runs in minutes rather than weeks."

To learn more about iSCanGuide, please visit our website.

About Advaita Bio

Advaita Bio builds AI-powered software for pathway analysis, variant interpretation, and single-cell analytics. Trusted by over 13,000 researchers and backed by nearly 20,000 peer-reviewed citations, the platform is built on two decades of scientifically validated algorithms to deliver biological insight that conventional tools miss.

Media contact

[email protected]

SOURCE Advaita Bio

Login to unlock3,569characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 16, 2026 at 11:12 AMUS Stocks Hit New Highs, Retail Investors Miss Out en masse: Tom Lee Says Next Rally Will Be Led by Them
  • Apr 13, 2026 at 01:07 AMU.S. Stocks Face a "Final Battle" as Hormuz Outcome Decides the Game: The Rash Never Win, the Patient Prevail
  • Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)

Related Stocks

Aadi Biosciences

Aadi Biosciences

USAADI

0.00%

Mustang Bio

Mustang Bio

USMBIO

+2.82%

10X Genomics

10X Genomics

USTXG

LongbridgeAI